Consultations

Proposal to continue with the current provider for storage and distribution services for funded pharmaceuticals

Pharmac is seeking feedback on a proposal to continue using Pharmacy Retailing (NZ) Limited trading as Onelink (“Onelink”) for the storage and distribution services of the funded pharmaceuticals; condoms, naloxone and nicotine replacement therapy (NRT) (“funded pharmaceuticals”) This...

Closed 24 July 2026

Proposal for the supply of dapsone tablets

The current brand of dapsone 25 and 50 mg tablets is being discontinued. We have sourced another brand but it is only available as 50 mg and 100 mg tablets. Let us know how this change might affect you or people you know.

Closed 26 June 2026

Proposal for new supply agreements for funded vaccines in the National Immunisation Schedule, and widened access to influenza vaccine

We are entering new supply arrangements for some funded vaccines. These changes will: guarantee continued supply of 17 funded vaccines and a diagnostic test widen access to a flu vaccine for children (from 6 months until their 5th birthday) widen access to pneumoccal vaccine for...

Closed 19 June 2026

Feedback on proposal to amend access criteria for type 2 diabetes medicines

We sought your feedback on a proposal for people living with Type 2 diabetes and at risk of cardio-renal complications. We are proposing to widen access to: empagliflozin (Jardiance) empagliflozin with metformin (Jardiamet) dulaglutide (Trulicity) ...

Closed 11 June 2026

Review of the Exceptional Circumstances Framework

Pharmac is reviewing its Exceptional Circumstances Framework (the Framework) after people told us it needs to work better and is hard to understand. The Framework includes the Named Patient Pharmaceutical Assessment (NPPA) policy and other ways Pharmac can fund medicines for...

Closed 7 June 2026